| Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer F Holst, PR Stahl, C Ruiz, O Hellwinkel, Z Jehan, M Wendland, A Lebeau, ... Nature genetics 39 (5), 655-660, 2007 | 478 | 2007 |
| The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis WJ Gibson, EA Hoivik, MK Halle, A Taylor-Weiner, AD Cherniack, A Berg, ... Nature genetics 48 (8), 848-855, 2016 | 196 | 2016 |
| Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease U Finckh, H von der Kammer, J Velden, T Michel, B Andresen, A Deng, ... Archives of neurology 57 (11), 1579-1583, 2000 | 160 | 2000 |
| KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer E Birkeland, E Wik, S Mjøs, EA Hoivik, J Trovik, HMJ Werner, ... British journal of cancer 107 (12), 1997-2004, 2012 | 98 | 2012 |
| Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers MB Raeder, E Birkeland, J Trovik, C Krakstad, S Shehata, S Schumacher, ... PloS one 8 (2), e54873, 2013 | 87 | 2013 |
| Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer E Burandt, G Jens, F Holst, F Jänicke, V Müller, A Quaas, M Choschzick, ... Breast cancer research and treatment 137, 745-753, 2013 | 67 | 2013 |
| Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients A Berg, EA Hoivik, S Mjøs, F Holst, HMJ Werner, IL Tangen, ... Oncotarget 6 (2), 1327, 2015 | 63 | 2015 |
| Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions A Lebeau, TJ Grob, F Holst, N Seyedi‐Fazlollahi, H Moch, L Terracciano, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2008 | 52 | 2008 |
| High phospho-Stathmin (Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition E Wik, E Birkeland, J Trovik, HMJ Werner, EA Hoivik, S Mjos, C Krakstad, ... Clinical cancer research 19 (9), 2331-2341, 2013 | 51 | 2013 |
| Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study MK Halle, AI Ojesina, H Engerud, K Woie, IL Tangen, F Holst, E Høivik, ... American journal of obstetrics and gynecology 217 (4), 432. e1-432. e17, 2017 | 45 | 2017 |
| PPFIA1 and CCND1 are frequently coamplified in breast cancer AM Dancau, L Wuth, M Waschow, F Holst, A Krohn, M Choschzick, ... Genes, Chromosomes and Cancer 49 (1), 1-8, 2010 | 34 | 2010 |
| Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate F Holst World journal of clinical oncology 7 (2), 160, 2016 | 33 | 2016 |
| Estrogen receptor gene amplification occurs rarely in ovarian cancer RM Issa, A Lebeau, T Grob, F Holst, H Moch, L Terracciano, ... Modern Pathology 22 (2), 191-196, 2009 | 28 | 2009 |
| PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer S Mjos, HMJ Werner, E Birkeland, F Holst, A Berg, MK Halle, IL Tangen, ... Scientific reports 7 (1), 10240, 2017 | 26 | 2017 |
| On the evidence for ESR1 amplification in breast cancer F Holst, CB Moelans, M Filipits, CF Singer, R Simon, PJ Van Diest Nature Reviews Cancer 12 (2), 149-149, 2012 | 24 | 2012 |
| PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma F Holst, HMJ Werner, S Mjøs, EA Hoivik, K Kusonmano, E Wik, A Berg, ... Clinical Cancer Research 25 (1), 334-345, 2019 | 22 | 2019 |
| Role of cyclin D1 amplification and expression in vulvar carcinomas M Choschzick, S Hess, P Tennstedt, F Holst, H Bohlken, F Gieseking, ... Human pathology 43 (9), 1386-1393, 2012 | 19 | 2012 |
| Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth F Holst, EA Hoivik, WJ Gibson, A Taylor-Weiner, SE Schumacher, ... Scientific reports 6 (1), 25521, 2016 | 17 | 2016 |
| Reply to “ESR1 gene amplification in breast cancer: a common phenomenon?” F Holst, P Stahl, O Hellwinkel, AM Dancau, A Krohn, L Wuth, C Heupel, ... Nature genetics 40 (7), 810-812, 2008 | 17 | 2008 |
| Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial–mesenchymal transition and PI3K alterations E Wik, J Trovik, K Kusonmano, E Birkeland, MB Raeder, I Pashtan, ... Gynecologic oncology 134 (3), 599-606, 2014 | 16 | 2014 |
